Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$357.45 - $567.26
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.76M
Market Cap
$84.93B
Enterprise Value$139.84B
Total Cash (Recent Filing)$7.50B
Total Debt (Recent Filing)$30.00B
Price to Earnings (P/E)14.7
Beta0.20
Next Earnings
Jul 16, 2025EPS Estimate
9.16Last Dividend Ex-Date
Jun 10, 2025Dividend Yield1.82%
Share Statistics
EPS (TTM)11.97
Shares Outstanding225,934,600
10 Day Avg. Volume1,541,098
30 Day Avg. Volume1,758,864
Financial Highlights & Ratios
PEG Ratio-10.93
Price to Book (P/B)3.39
Price to Sales (P/S)0.00
P/FCF Ratio16.99
Enterprise Value/Market Cap1.65
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit1.22
Enterprise Value/Ebitda3.29
Forecast
1Y Price Target
$498.00Price Target Upside32.97% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
Elevance Health News
Bulls Say, Bears Say
Bulls Say
Carelon Services PerformanceCarelon Services revenue increased significantly, driven by mergers and acquisitions, with new behavioral and post-acute risk-based contracts highlighting business momentum.
Medicare Advantage GrowthElevance Health's Medicare Advantage membership grew by 11.8% year over year, reaching the high-end of company guidance.
Revenue GrowthElevance Health's revenue increased by 15.4% year over year, surpassing previous estimates.
Bears Say
Health Benefits Division PerformanceThe Health Benefits division's EBIT margin fell short of expectations, negatively impacting overall performance.
Member Effectuation RatesThe company expects membership attrition as effectuation rates on renewing members are tracking below initial expectations.
Utilization PressureThe exchange business saw higher utilization than anticipated, indicating emerging pressure.
Ownership Overview
0.14% Insiders
27.05% Mutual Funds
27.17% Other Institutional Investors
23.25% Public Companies and Individual Investors
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $357.45 and its highest was $567.26 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $84.93B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Jul 16, 2025 which is in 24 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Apr 22, 2025. The company reported $11.97 earnings per share for the quarter, beating the consensus estimate of $11.412 by $0.558.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.82%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 9.16.
How many shares outstanding does Elevance Health have?
Elevance Health has 225,934,600 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $11.97 in its last earnings report, beating expectations of $11.412. Following the earnings report the stock price went up 2.265%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$498.00 (32.97% Upside)
$498.00 (32.97% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 94%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 322.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.86%
12-Months-Change
Fundamentals
Return on Equity
14.24%
Trailing 12-Months
Asset Growth
6.99%
Trailing 12-Months
Company Description
Elevance Health
Elevance Health (ELV) is a leading health benefits company primarily operating in the United States. It offers a comprehensive range of healthcare plans and services aimed at improving health outcomes while lowering costs. The company's core offerings include medical, pharmaceutical, dental, vision, and life insurance products, catering to individual, group, Medicaid, and Medicare markets. Elevance Health operates through various well-known subsidiaries such as Anthem Blue Cross and Blue Shield, and it is recognized for its extensive provider networks and commitment to value-based care.
ELV Company Deck
ELV Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Elevance Health started 2025 with robust revenue growth and strong performances in key segments like Medicare Advantage and Carelon Services. However, the company faces challenges with elevated Medicaid costs and lower-than-expected ACA membership effectuation rates. Overall, the positive achievements in strategic areas were tempered by ongoing cost pressures.Read More>ELV Stock 12 Month Forecast
Average Price Target
$498.00
▲(32.97%Upside)